nodes	percent_of_prediction	percent_of_DWPC	metapath
Nortriptyline—ADRA1D—polycystic ovary syndrome	0.333	0.412	CbGaD
Nortriptyline—ADRA1B—polycystic ovary syndrome	0.284	0.351	CbGaD
Nortriptyline—ADRA1A—polycystic ovary syndrome	0.191	0.237	CbGaD
Nortriptyline—CYP2C19—urine—polycystic ovary syndrome	0.00193	0.0736	CbGeAlD
Nortriptyline—CYP1A2—urine—polycystic ovary syndrome	0.00158	0.0601	CbGeAlD
Nortriptyline—CYP2C9—urine—polycystic ovary syndrome	0.0015	0.057	CbGeAlD
Nortriptyline—CYP2E1—urine—polycystic ovary syndrome	0.00142	0.0541	CbGeAlD
Nortriptyline—HTR2A—urine—polycystic ovary syndrome	0.00124	0.047	CbGeAlD
Nortriptyline—CYP3A4—urine—polycystic ovary syndrome	0.00114	0.0435	CbGeAlD
Nortriptyline—CYP2D6—urine—polycystic ovary syndrome	0.00113	0.0428	CbGeAlD
Nortriptyline—Appetite absent—Metformin—polycystic ovary syndrome	0.000956	0.118	CcSEcCtD
Nortriptyline—ORM1—endometrium—polycystic ovary syndrome	0.000648	0.0247	CbGeAlD
Nortriptyline—ADRA1D—endocrine gland—polycystic ovary syndrome	0.000552	0.021	CbGeAlD
Nortriptyline—Epinastine—ADRA1A—polycystic ovary syndrome	0.000528	0.134	CrCbGaD
Nortriptyline—ALB—adrenal gland—polycystic ovary syndrome	0.000459	0.0175	CbGeAlD
Nortriptyline—ORM1—endocrine gland—polycystic ovary syndrome	0.000454	0.0173	CbGeAlD
Nortriptyline—CHRM3—adipose tissue—polycystic ovary syndrome	0.000444	0.0169	CbGeAlD
Nortriptyline—Doxepin—ADRA1D—polycystic ovary syndrome	0.000427	0.108	CrCbGaD
Nortriptyline—CHRM2—endocrine gland—polycystic ovary syndrome	0.000424	0.0161	CbGeAlD
Nortriptyline—ADRA1A—adipose tissue—polycystic ovary syndrome	0.000407	0.0155	CbGeAlD
Nortriptyline—DRD2—pituitary gland—polycystic ovary syndrome	0.000401	0.0153	CbGeAlD
Nortriptyline—HTR2A—embryo—polycystic ovary syndrome	0.000399	0.0152	CbGeAlD
Nortriptyline—HTR1A—adrenal gland—polycystic ovary syndrome	0.000396	0.0151	CbGeAlD
Nortriptyline—SLC6A2—adrenal gland—polycystic ovary syndrome	0.000393	0.015	CbGeAlD
Nortriptyline—SLC6A4—endocrine gland—polycystic ovary syndrome	0.000387	0.0147	CbGeAlD
Nortriptyline—CHRM1—endocrine gland—polycystic ovary syndrome	0.000386	0.0147	CbGeAlD
Nortriptyline—Trimipramine—ADRA1B—polycystic ovary syndrome	0.000382	0.0969	CrCbGaD
Nortriptyline—CHRM3—female gonad—polycystic ovary syndrome	0.000371	0.0141	CbGeAlD
Nortriptyline—ADRA1A—adrenal gland—polycystic ovary syndrome	0.000365	0.0139	CbGeAlD
Nortriptyline—Doxepin—ADRA1B—polycystic ovary syndrome	0.000364	0.0923	CrCbGaD
Nortriptyline—HRH1—endometrium—polycystic ovary syndrome	0.00035	0.0133	CbGeAlD
Nortriptyline—CHRM3—endocrine gland—polycystic ovary syndrome	0.000345	0.0131	CbGeAlD
Nortriptyline—HTR1A—endocrine gland—polycystic ovary syndrome	0.000344	0.0131	CbGeAlD
Nortriptyline—CYP2C19—vagina—polycystic ovary syndrome	0.000343	0.013	CbGeAlD
Nortriptyline—SLC6A2—endocrine gland—polycystic ovary syndrome	0.000341	0.013	CbGeAlD
Nortriptyline—Imipramine—ADRA1D—polycystic ovary syndrome	0.000332	0.0842	CrCbGaD
Nortriptyline—Amitriptyline—ADRA1D—polycystic ovary syndrome	0.00033	0.0837	CrCbGaD
Nortriptyline—CYP3A5—adipose tissue—polycystic ovary syndrome	0.000325	0.0124	CbGeAlD
Nortriptyline—PTGS1—endometrium—polycystic ovary syndrome	0.000324	0.0123	CbGeAlD
Nortriptyline—CYP2C19—endocrine gland—polycystic ovary syndrome	0.000321	0.0122	CbGeAlD
Nortriptyline—ADRA1A—endocrine gland—polycystic ovary syndrome	0.000317	0.0121	CbGeAlD
Nortriptyline—HRH1—adipose tissue—polycystic ovary syndrome	0.000315	0.012	CbGeAlD
Nortriptyline—DRD2—endocrine gland—polycystic ovary syndrome	0.000311	0.0118	CbGeAlD
Nortriptyline—PTGS1—uterus—polycystic ovary syndrome	0.000298	0.0114	CbGeAlD
Nortriptyline—PTGS1—pituitary gland—polycystic ovary syndrome	0.000293	0.0111	CbGeAlD
Nortriptyline—PTGS1—adipose tissue—polycystic ovary syndrome	0.000292	0.0111	CbGeAlD
Nortriptyline—Sweating increased—Metformin—polycystic ovary syndrome	0.000291	0.0359	CcSEcCtD
Nortriptyline—Imipramine—ADRA1B—polycystic ovary syndrome	0.000283	0.0718	CrCbGaD
Nortriptyline—HRH1—adrenal gland—polycystic ovary syndrome	0.000283	0.0108	CbGeAlD
Nortriptyline—Amitriptyline—ADRA1B—polycystic ovary syndrome	0.000282	0.0714	CrCbGaD
Nortriptyline—CYP2E1—adrenal gland—polycystic ovary syndrome	0.000272	0.0103	CbGeAlD
Nortriptyline—CYP3A5—female gonad—polycystic ovary syndrome	0.000272	0.0103	CbGeAlD
Nortriptyline—CYP3A5—vagina—polycystic ovary syndrome	0.00027	0.0103	CbGeAlD
Nortriptyline—Drowsiness—Metformin—polycystic ovary syndrome	0.000266	0.0329	CcSEcCtD
Nortriptyline—HTR2A—pituitary gland—polycystic ovary syndrome	0.000264	0.0101	CbGeAlD
Nortriptyline—HRH1—female gonad—polycystic ovary syndrome	0.000264	0.01	CbGeAlD
Nortriptyline—HRH1—vagina—polycystic ovary syndrome	0.000262	0.00997	CbGeAlD
Nortriptyline—CYP1A2—endocrine gland—polycystic ovary syndrome	0.000262	0.00997	CbGeAlD
Nortriptyline—PTGS1—adrenal gland—polycystic ovary syndrome	0.000262	0.00996	CbGeAlD
Nortriptyline—Neuropathy peripheral—Metformin—polycystic ovary syndrome	0.000261	0.0322	CcSEcCtD
Nortriptyline—Trimipramine—ADRA1A—polycystic ovary syndrome	0.000257	0.0652	CrCbGaD
Nortriptyline—CYP3A5—endocrine gland—polycystic ovary syndrome	0.000253	0.00961	CbGeAlD
Nortriptyline—CYP2C9—endocrine gland—polycystic ovary syndrome	0.000249	0.00946	CbGeAlD
Nortriptyline—HRH1—endocrine gland—polycystic ovary syndrome	0.000245	0.00933	CbGeAlD
Nortriptyline—Doxepin—ADRA1A—polycystic ovary syndrome	0.000245	0.0621	CrCbGaD
Nortriptyline—PTGS1—female gonad—polycystic ovary syndrome	0.000244	0.00929	CbGeAlD
Nortriptyline—PTGS1—vagina—polycystic ovary syndrome	0.000243	0.00923	CbGeAlD
Nortriptyline—Hepatitis—Metformin—polycystic ovary syndrome	0.000239	0.0295	CcSEcCtD
Nortriptyline—Hypoaesthesia—Metformin—polycystic ovary syndrome	0.000238	0.0293	CcSEcCtD
Nortriptyline—HTR2A—adrenal gland—polycystic ovary syndrome	0.000236	0.00899	CbGeAlD
Nortriptyline—CYP2E1—endocrine gland—polycystic ovary syndrome	0.000236	0.00897	CbGeAlD
Nortriptyline—Oedema peripheral—Metformin—polycystic ovary syndrome	0.000235	0.0291	CcSEcCtD
Nortriptyline—PTGS1—endocrine gland—polycystic ovary syndrome	0.000227	0.00864	CbGeAlD
Nortriptyline—Eye disorder—Metformin—polycystic ovary syndrome	0.000223	0.0276	CcSEcCtD
Nortriptyline—Flushing—Metformin—polycystic ovary syndrome	0.000222	0.0274	CcSEcCtD
Nortriptyline—HTR2A—vagina—polycystic ovary syndrome	0.000219	0.00833	CbGeAlD
Nortriptyline—HTR2A—endocrine gland—polycystic ovary syndrome	0.000205	0.00779	CbGeAlD
Nortriptyline—Dysgeusia—Metformin—polycystic ovary syndrome	0.000204	0.0251	CcSEcCtD
Nortriptyline—CYP2D6—female gonad—polycystic ovary syndrome	0.000201	0.00763	CbGeAlD
Nortriptyline—Vision blurred—Metformin—polycystic ovary syndrome	0.000196	0.0242	CcSEcCtD
Nortriptyline—Tremor—Metformin—polycystic ovary syndrome	0.000195	0.0241	CcSEcCtD
Nortriptyline—Ill-defined disorder—Metformin—polycystic ovary syndrome	0.000193	0.0238	CcSEcCtD
Nortriptyline—Imipramine—ADRA1A—polycystic ovary syndrome	0.000191	0.0484	CrCbGaD
Nortriptyline—CYP3A4—endocrine gland—polycystic ovary syndrome	0.00019	0.00721	CbGeAlD
Nortriptyline—Amitriptyline—ADRA1A—polycystic ovary syndrome	0.00019	0.0481	CrCbGaD
Nortriptyline—Malaise—Metformin—polycystic ovary syndrome	0.000188	0.0232	CcSEcCtD
Nortriptyline—CYP2D6—endocrine gland—polycystic ovary syndrome	0.000187	0.0071	CbGeAlD
Nortriptyline—Syncope—Metformin—polycystic ovary syndrome	0.000187	0.023	CcSEcCtD
Nortriptyline—Palpitations—Metformin—polycystic ovary syndrome	0.000184	0.0227	CcSEcCtD
Nortriptyline—Loss of consciousness—Metformin—polycystic ovary syndrome	0.000183	0.0226	CcSEcCtD
Nortriptyline—Hypertension—Metformin—polycystic ovary syndrome	0.00018	0.0222	CcSEcCtD
Nortriptyline—Discomfort—Metformin—polycystic ovary syndrome	0.000175	0.0216	CcSEcCtD
Nortriptyline—Oedema—Metformin—polycystic ovary syndrome	0.00017	0.021	CcSEcCtD
Nortriptyline—Shock—Metformin—polycystic ovary syndrome	0.000167	0.0206	CcSEcCtD
Nortriptyline—Thrombocytopenia—Metformin—polycystic ovary syndrome	0.000166	0.0205	CcSEcCtD
Nortriptyline—Hyperhidrosis—Metformin—polycystic ovary syndrome	0.000164	0.0203	CcSEcCtD
Nortriptyline—Anorexia—Metformin—polycystic ovary syndrome	0.000162	0.02	CcSEcCtD
Nortriptyline—Hypotension—Metformin—polycystic ovary syndrome	0.000159	0.0196	CcSEcCtD
Nortriptyline—Paraesthesia—Metformin—polycystic ovary syndrome	0.000152	0.0188	CcSEcCtD
Nortriptyline—Somnolence—Metformin—polycystic ovary syndrome	0.000151	0.0186	CcSEcCtD
Nortriptyline—Dyspepsia—Metformin—polycystic ovary syndrome	0.000149	0.0184	CcSEcCtD
Nortriptyline—Decreased appetite—Metformin—polycystic ovary syndrome	0.000148	0.0182	CcSEcCtD
Nortriptyline—Fatigue—Metformin—polycystic ovary syndrome	0.000146	0.0181	CcSEcCtD
Nortriptyline—Constipation—Metformin—polycystic ovary syndrome	0.000145	0.0179	CcSEcCtD
Nortriptyline—Feeling abnormal—Metformin—polycystic ovary syndrome	0.00014	0.0173	CcSEcCtD
Nortriptyline—Urticaria—Metformin—polycystic ovary syndrome	0.000135	0.0166	CcSEcCtD
Nortriptyline—Abdominal pain—Metformin—polycystic ovary syndrome	0.000134	0.0166	CcSEcCtD
Nortriptyline—Desipramine—ADRB2—polycystic ovary syndrome	0.000134	0.0339	CrCbGaD
Nortriptyline—Asthenia—Metformin—polycystic ovary syndrome	0.000122	0.015	CcSEcCtD
Nortriptyline—Pruritus—Metformin—polycystic ovary syndrome	0.00012	0.0148	CcSEcCtD
Nortriptyline—Diarrhoea—Metformin—polycystic ovary syndrome	0.000116	0.0143	CcSEcCtD
Nortriptyline—Dizziness—Metformin—polycystic ovary syndrome	0.000112	0.0139	CcSEcCtD
Nortriptyline—Vomiting—Metformin—polycystic ovary syndrome	0.000108	0.0133	CcSEcCtD
Nortriptyline—Rash—Metformin—polycystic ovary syndrome	0.000107	0.0132	CcSEcCtD
Nortriptyline—Dermatitis—Metformin—polycystic ovary syndrome	0.000107	0.0132	CcSEcCtD
Nortriptyline—Headache—Metformin—polycystic ovary syndrome	0.000106	0.0131	CcSEcCtD
Nortriptyline—Nausea—Metformin—polycystic ovary syndrome	0.000101	0.0124	CcSEcCtD
Nortriptyline—CHRM3—Signaling Pathways—GNAS—polycystic ovary syndrome	4.86e-06	3.17e-05	CbGpPWpGaD
Nortriptyline—CHRM5—Signaling Pathways—IRS1—polycystic ovary syndrome	4.84e-06	3.15e-05	CbGpPWpGaD
Nortriptyline—CHRM4—Signaling Pathways—INS—polycystic ovary syndrome	4.84e-06	3.15e-05	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—GNAS—polycystic ovary syndrome	4.81e-06	3.13e-05	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—GNAS—polycystic ovary syndrome	4.8e-06	3.13e-05	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—NCOR1—polycystic ovary syndrome	4.74e-06	3.09e-05	CbGpPWpGaD
Nortriptyline—CYP1A2—Metabolism—YAP1—polycystic ovary syndrome	4.72e-06	3.08e-05	CbGpPWpGaD
Nortriptyline—ALB—Metabolism—CYP19A1—polycystic ovary syndrome	4.71e-06	3.07e-05	CbGpPWpGaD
Nortriptyline—HTR6—Signaling Pathways—SERPINE1—polycystic ovary syndrome	4.71e-06	3.07e-05	CbGpPWpGaD
Nortriptyline—CHRM4—Signaling Pathways—IGF1—polycystic ovary syndrome	4.68e-06	3.05e-05	CbGpPWpGaD
Nortriptyline—CHRM4—Signaling Pathways—AKT2—polycystic ovary syndrome	4.68e-06	3.05e-05	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—NCOR1—polycystic ovary syndrome	4.67e-06	3.04e-05	CbGpPWpGaD
Nortriptyline—CYP2E1—Metabolism—NCOR1—polycystic ovary syndrome	4.66e-06	3.04e-05	CbGpPWpGaD
Nortriptyline—CHRM5—Signaling Pathways—POMC—polycystic ovary syndrome	4.66e-06	3.04e-05	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—NCOR1—polycystic ovary syndrome	4.66e-06	3.03e-05	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—NRG1—polycystic ovary syndrome	4.66e-06	3.03e-05	CbGpPWpGaD
Nortriptyline—CYP3A5—Metabolism—NCOR1—polycystic ovary syndrome	4.65e-06	3.03e-05	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—NCOR1—polycystic ovary syndrome	4.64e-06	3.03e-05	CbGpPWpGaD
Nortriptyline—CHRM5—Signaling Pathways—INS—polycystic ovary syndrome	4.63e-06	3.02e-05	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—NCOR1—polycystic ovary syndrome	4.63e-06	3.02e-05	CbGpPWpGaD
Nortriptyline—CYP2C19—Metabolism—TH—polycystic ovary syndrome	4.63e-06	3.01e-05	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—NCOR1—polycystic ovary syndrome	4.58e-06	2.99e-05	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—NRG1—polycystic ovary syndrome	4.58e-06	2.99e-05	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—NRG1—polycystic ovary syndrome	4.57e-06	2.98e-05	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—NCOR1—polycystic ovary syndrome	4.57e-06	2.98e-05	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—NRG1—polycystic ovary syndrome	4.56e-06	2.97e-05	CbGpPWpGaD
Nortriptyline—ADRA1D—Signaling Pathways—IRS1—polycystic ovary syndrome	4.55e-06	2.96e-05	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—NRG1—polycystic ovary syndrome	4.54e-06	2.96e-05	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling Pathways—IRS2—polycystic ovary syndrome	4.54e-06	2.96e-05	CbGpPWpGaD
Nortriptyline—CYP1A2—Metabolism—NAMPT—polycystic ovary syndrome	4.54e-06	2.96e-05	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling Pathways—IRS2—polycystic ovary syndrome	4.52e-06	2.94e-05	CbGpPWpGaD
Nortriptyline—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	4.51e-06	2.94e-05	CbGpPWpGaD
Nortriptyline—CYP2C19—Metabolism—SLC2A4—polycystic ovary syndrome	4.5e-06	2.93e-05	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—NRG1—polycystic ovary syndrome	4.5e-06	2.93e-05	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—NRG1—polycystic ovary syndrome	4.49e-06	2.92e-05	CbGpPWpGaD
Nortriptyline—CHRM5—Signaling Pathways—IGF1—polycystic ovary syndrome	4.48e-06	2.92e-05	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—LHB—polycystic ovary syndrome	4.48e-06	2.92e-05	CbGpPWpGaD
Nortriptyline—CYP1A2—Metabolism—CYP11A1—polycystic ovary syndrome	4.48e-06	2.92e-05	CbGpPWpGaD
Nortriptyline—CHRM5—Signaling Pathways—AKT2—polycystic ovary syndrome	4.48e-06	2.92e-05	CbGpPWpGaD
Nortriptyline—PTGS1—Metabolism—PPARG—polycystic ovary syndrome	4.47e-06	2.91e-05	CbGpPWpGaD
Nortriptyline—CYP1A2—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	4.45e-06	2.9e-05	CbGpPWpGaD
Nortriptyline—CHRM4—Signaling Pathways—SERPINE1—polycystic ovary syndrome	4.45e-06	2.9e-05	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling Pathways—LEP—polycystic ovary syndrome	4.45e-06	2.9e-05	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling Pathways—LEP—polycystic ovary syndrome	4.42e-06	2.88e-05	CbGpPWpGaD
Nortriptyline—CYP2E1—Metabolism—CYP1A1—polycystic ovary syndrome	4.42e-06	2.88e-05	CbGpPWpGaD
Nortriptyline—CYP3A5—Metabolism—CYP1A1—polycystic ovary syndrome	4.41e-06	2.87e-05	CbGpPWpGaD
Nortriptyline—PTGS1—Metabolism—POMC—polycystic ovary syndrome	4.41e-06	2.87e-05	CbGpPWpGaD
Nortriptyline—ALB—Hemostasis—VEGFA—polycystic ovary syndrome	4.39e-06	2.86e-05	CbGpPWpGaD
Nortriptyline—PTGS1—Metabolism—INS—polycystic ovary syndrome	4.39e-06	2.86e-05	CbGpPWpGaD
Nortriptyline—ADRA1D—Signaling Pathways—POMC—polycystic ovary syndrome	4.38e-06	2.86e-05	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—HSD3B2—polycystic ovary syndrome	4.38e-06	2.85e-05	CbGpPWpGaD
Nortriptyline—ADRA1D—Signaling Pathways—INS—polycystic ovary syndrome	4.36e-06	2.84e-05	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling Pathways—IRS2—polycystic ovary syndrome	4.33e-06	2.82e-05	CbGpPWpGaD
Nortriptyline—CHRM5—Signaling Pathways—SERPINE1—polycystic ovary syndrome	4.26e-06	2.77e-05	CbGpPWpGaD
Nortriptyline—CYP2D6—Metabolism—TH—polycystic ovary syndrome	4.26e-06	2.77e-05	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—AKR1C1—polycystic ovary syndrome	4.24e-06	2.76e-05	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling Pathways—LEP—polycystic ovary syndrome	4.23e-06	2.76e-05	CbGpPWpGaD
Nortriptyline—CYP1A2—Metabolism—AKR1C3—polycystic ovary syndrome	4.23e-06	2.76e-05	CbGpPWpGaD
Nortriptyline—CYP2C19—Metabolism—CYP19A1—polycystic ovary syndrome	4.23e-06	2.76e-05	CbGpPWpGaD
Nortriptyline—CYP2C9—Metabolism—TH—polycystic ovary syndrome	4.22e-06	2.75e-05	CbGpPWpGaD
Nortriptyline—ADRA1D—Signaling Pathways—IGF1—polycystic ovary syndrome	4.21e-06	2.75e-05	CbGpPWpGaD
Nortriptyline—ADRA1D—Signaling Pathways—AKT2—polycystic ovary syndrome	4.21e-06	2.74e-05	CbGpPWpGaD
Nortriptyline—ALB—Metabolism—GNAS—polycystic ovary syndrome	4.21e-06	2.74e-05	CbGpPWpGaD
Nortriptyline—CYP1A2—Metabolism—CYP17A1—polycystic ovary syndrome	4.17e-06	2.71e-05	CbGpPWpGaD
Nortriptyline—CYP2D6—Metabolism—SLC2A4—polycystic ovary syndrome	4.14e-06	2.7e-05	CbGpPWpGaD
Nortriptyline—CYP2E1—Metabolism—MTHFR—polycystic ovary syndrome	4.12e-06	2.69e-05	CbGpPWpGaD
Nortriptyline—CYP3A5—Metabolism—MTHFR—polycystic ovary syndrome	4.11e-06	2.68e-05	CbGpPWpGaD
Nortriptyline—CYP2C9—Metabolism—SLC2A4—polycystic ovary syndrome	4.1e-06	2.67e-05	CbGpPWpGaD
Nortriptyline—ALB—Metabolism—NCOR1—polycystic ovary syndrome	4.01e-06	2.61e-05	CbGpPWpGaD
Nortriptyline—ADRA1D—Signaling Pathways—SERPINE1—polycystic ovary syndrome	4e-06	2.61e-05	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—IRS2—polycystic ovary syndrome	3.99e-06	2.6e-05	CbGpPWpGaD
Nortriptyline—CHRM3—Metabolism—PPARG—polycystic ovary syndrome	3.97e-06	2.58e-05	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling Pathways—IRS1—polycystic ovary syndrome	3.97e-06	2.58e-05	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling Pathways—IRS1—polycystic ovary syndrome	3.94e-06	2.57e-05	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—IRS2—polycystic ovary syndrome	3.92e-06	2.56e-05	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—IRS2—polycystic ovary syndrome	3.92e-06	2.55e-05	CbGpPWpGaD
Nortriptyline—CHRM3—Metabolism—POMC—polycystic ovary syndrome	3.91e-06	2.55e-05	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—SULT2A1—polycystic ovary syndrome	3.9e-06	2.54e-05	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—IRS2—polycystic ovary syndrome	3.9e-06	2.54e-05	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—LEP—polycystic ovary syndrome	3.9e-06	2.54e-05	CbGpPWpGaD
Nortriptyline—CYP2D6—Metabolism—CYP19A1—polycystic ovary syndrome	3.89e-06	2.54e-05	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—IRS2—polycystic ovary syndrome	3.89e-06	2.54e-05	CbGpPWpGaD
Nortriptyline—CHRM3—Metabolism—INS—polycystic ovary syndrome	3.89e-06	2.53e-05	CbGpPWpGaD
Nortriptyline—CYP2C9—Metabolism—CYP19A1—polycystic ovary syndrome	3.86e-06	2.51e-05	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—IRS2—polycystic ovary syndrome	3.85e-06	2.51e-05	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—IRS2—polycystic ovary syndrome	3.84e-06	2.5e-05	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—LEP—polycystic ovary syndrome	3.84e-06	2.5e-05	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—LEP—polycystic ovary syndrome	3.83e-06	2.5e-05	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—LEP—polycystic ovary syndrome	3.82e-06	2.49e-05	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling Pathways—POMC—polycystic ovary syndrome	3.82e-06	2.49e-05	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—LEP—polycystic ovary syndrome	3.81e-06	2.48e-05	CbGpPWpGaD
Nortriptyline—ALB—Metabolism—CYP1A1—polycystic ovary syndrome	3.8e-06	2.48e-05	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling Pathways—POMC—polycystic ovary syndrome	3.8e-06	2.48e-05	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling Pathways—INS—polycystic ovary syndrome	3.8e-06	2.47e-05	CbGpPWpGaD
Nortriptyline—HTR6—Signaling by GPCR—IL6—polycystic ovary syndrome	3.79e-06	2.47e-05	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—RRM2—polycystic ovary syndrome	3.78e-06	2.46e-05	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling Pathways—INS—polycystic ovary syndrome	3.78e-06	2.46e-05	CbGpPWpGaD
Nortriptyline—CYP2C19—Metabolism—GNAS—polycystic ovary syndrome	3.78e-06	2.46e-05	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling Pathways—IRS1—polycystic ovary syndrome	3.78e-06	2.46e-05	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—LEP—polycystic ovary syndrome	3.77e-06	2.46e-05	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—LEP—polycystic ovary syndrome	3.76e-06	2.45e-05	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling Pathways—IGF1—polycystic ovary syndrome	3.67e-06	2.39e-05	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling Pathways—AKT2—polycystic ovary syndrome	3.67e-06	2.39e-05	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling Pathways—IGF1—polycystic ovary syndrome	3.65e-06	2.38e-05	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling Pathways—AKT2—polycystic ovary syndrome	3.65e-06	2.38e-05	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—YAP1—polycystic ovary syndrome	3.64e-06	2.38e-05	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling Pathways—POMC—polycystic ovary syndrome	3.64e-06	2.37e-05	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling Pathways—INS—polycystic ovary syndrome	3.62e-06	2.36e-05	CbGpPWpGaD
Nortriptyline—CYP1A2—Metabolism—TH—polycystic ovary syndrome	3.6e-06	2.35e-05	CbGpPWpGaD
Nortriptyline—CYP2C19—Metabolism—NCOR1—polycystic ovary syndrome	3.6e-06	2.34e-05	CbGpPWpGaD
Nortriptyline—CHRM4—Signaling by GPCR—IL6—polycystic ovary syndrome	3.58e-06	2.33e-05	CbGpPWpGaD
Nortriptyline—ALB—Metabolism—MTHFR—polycystic ovary syndrome	3.54e-06	2.31e-05	CbGpPWpGaD
Nortriptyline—CYP1A2—Metabolism—SLC2A4—polycystic ovary syndrome	3.51e-06	2.28e-05	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—NAMPT—polycystic ovary syndrome	3.5e-06	2.28e-05	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling Pathways—IGF1—polycystic ovary syndrome	3.5e-06	2.28e-05	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling Pathways—AKT2—polycystic ovary syndrome	3.5e-06	2.28e-05	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling Pathways—SERPINE1—polycystic ovary syndrome	3.49e-06	2.27e-05	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—IRS1—polycystic ovary syndrome	3.48e-06	2.27e-05	CbGpPWpGaD
Nortriptyline—CYP2D6—Metabolism—GNAS—polycystic ovary syndrome	3.47e-06	2.26e-05	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling Pathways—SERPINE1—polycystic ovary syndrome	3.47e-06	2.26e-05	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—CYP11A1—polycystic ovary syndrome	3.46e-06	2.25e-05	CbGpPWpGaD
Nortriptyline—CYP2C9—Metabolism—GNAS—polycystic ovary syndrome	3.44e-06	2.24e-05	CbGpPWpGaD
Nortriptyline—CHRM5—Signaling by GPCR—IL6—polycystic ovary syndrome	3.43e-06	2.23e-05	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—IRS1—polycystic ovary syndrome	3.43e-06	2.23e-05	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—IRS1—polycystic ovary syndrome	3.42e-06	2.23e-05	CbGpPWpGaD
Nortriptyline—CYP2C19—Metabolism—CYP1A1—polycystic ovary syndrome	3.41e-06	2.22e-05	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—IRS1—polycystic ovary syndrome	3.41e-06	2.22e-05	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—IRS1—polycystic ovary syndrome	3.4e-06	2.21e-05	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—IRS1—polycystic ovary syndrome	3.36e-06	2.19e-05	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—IRS1—polycystic ovary syndrome	3.35e-06	2.19e-05	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—POMC—polycystic ovary syndrome	3.35e-06	2.18e-05	CbGpPWpGaD
Nortriptyline—CYP2E1—Metabolism—PPARG—polycystic ovary syndrome	3.34e-06	2.18e-05	CbGpPWpGaD
Nortriptyline—CYP3A5—Metabolism—PPARG—polycystic ovary syndrome	3.33e-06	2.17e-05	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—INS—polycystic ovary syndrome	3.33e-06	2.17e-05	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling Pathways—SERPINE1—polycystic ovary syndrome	3.32e-06	2.16e-05	CbGpPWpGaD
Nortriptyline—CYP2D6—Metabolism—NCOR1—polycystic ovary syndrome	3.31e-06	2.16e-05	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—POMC—polycystic ovary syndrome	3.3e-06	2.15e-05	CbGpPWpGaD
Nortriptyline—CYP1A2—Metabolism—CYP19A1—polycystic ovary syndrome	3.3e-06	2.15e-05	CbGpPWpGaD
Nortriptyline—CYP2E1—Metabolism—POMC—polycystic ovary syndrome	3.3e-06	2.15e-05	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—POMC—polycystic ovary syndrome	3.29e-06	2.15e-05	CbGpPWpGaD
Nortriptyline—CYP3A5—Metabolism—POMC—polycystic ovary syndrome	3.29e-06	2.14e-05	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—POMC—polycystic ovary syndrome	3.28e-06	2.14e-05	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—INS—polycystic ovary syndrome	3.28e-06	2.14e-05	CbGpPWpGaD
Nortriptyline—CYP2C9—Metabolism—NCOR1—polycystic ovary syndrome	3.28e-06	2.14e-05	CbGpPWpGaD
Nortriptyline—CYP2E1—Metabolism—INS—polycystic ovary syndrome	3.28e-06	2.14e-05	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—INS—polycystic ovary syndrome	3.27e-06	2.13e-05	CbGpPWpGaD
Nortriptyline—CYP3A5—Metabolism—INS—polycystic ovary syndrome	3.27e-06	2.13e-05	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—POMC—polycystic ovary syndrome	3.27e-06	2.13e-05	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—AKR1C3—polycystic ovary syndrome	3.27e-06	2.13e-05	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—INS—polycystic ovary syndrome	3.26e-06	2.13e-05	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—INS—polycystic ovary syndrome	3.25e-06	2.12e-05	CbGpPWpGaD
Nortriptyline—HTR6—Signaling Pathways—VEGFA—polycystic ovary syndrome	3.24e-06	2.11e-05	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—POMC—polycystic ovary syndrome	3.24e-06	2.11e-05	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—POMC—polycystic ovary syndrome	3.23e-06	2.1e-05	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—IGF1—polycystic ovary syndrome	3.22e-06	2.1e-05	CbGpPWpGaD
Nortriptyline—ADRA1D—Signaling by GPCR—IL6—polycystic ovary syndrome	3.22e-06	2.1e-05	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—AKT2—polycystic ovary syndrome	3.22e-06	2.1e-05	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—INS—polycystic ovary syndrome	3.22e-06	2.1e-05	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—CYP17A1—polycystic ovary syndrome	3.22e-06	2.1e-05	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—INS—polycystic ovary syndrome	3.21e-06	2.09e-05	CbGpPWpGaD
Nortriptyline—CYP2C19—Metabolism—MTHFR—polycystic ovary syndrome	3.18e-06	2.07e-05	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—IGF1—polycystic ovary syndrome	3.17e-06	2.07e-05	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—AKT2—polycystic ovary syndrome	3.17e-06	2.07e-05	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—IGF1—polycystic ovary syndrome	3.17e-06	2.06e-05	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—AKT2—polycystic ovary syndrome	3.16e-06	2.06e-05	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—IGF1—polycystic ovary syndrome	3.16e-06	2.06e-05	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—AKT2—polycystic ovary syndrome	3.15e-06	2.06e-05	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—IGF1—polycystic ovary syndrome	3.15e-06	2.05e-05	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—AKT2—polycystic ovary syndrome	3.14e-06	2.05e-05	CbGpPWpGaD
Nortriptyline—CYP2D6—Metabolism—CYP1A1—polycystic ovary syndrome	3.14e-06	2.04e-05	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—IGF1—polycystic ovary syndrome	3.12e-06	2.03e-05	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—AKT2—polycystic ovary syndrome	3.11e-06	2.03e-05	CbGpPWpGaD
Nortriptyline—CYP2C9—Metabolism—CYP1A1—polycystic ovary syndrome	3.11e-06	2.03e-05	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—IGF1—polycystic ovary syndrome	3.11e-06	2.02e-05	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—AKT2—polycystic ovary syndrome	3.1e-06	2.02e-05	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—SERPINE1—polycystic ovary syndrome	3.06e-06	2e-05	CbGpPWpGaD
Nortriptyline—CHRM4—Signaling Pathways—VEGFA—polycystic ovary syndrome	3.06e-06	1.99e-05	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—SERPINE1—polycystic ovary syndrome	3.01e-06	1.96e-05	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—SERPINE1—polycystic ovary syndrome	3.01e-06	1.96e-05	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—SERPINE1—polycystic ovary syndrome	3e-06	1.95e-05	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—SERPINE1—polycystic ovary syndrome	2.99e-06	1.95e-05	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—SERPINE1—polycystic ovary syndrome	2.96e-06	1.93e-05	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—SERPINE1—polycystic ovary syndrome	2.95e-06	1.92e-05	CbGpPWpGaD
Nortriptyline—CYP1A2—Metabolism—GNAS—polycystic ovary syndrome	2.94e-06	1.92e-05	CbGpPWpGaD
Nortriptyline—CHRM5—Signaling Pathways—VEGFA—polycystic ovary syndrome	2.93e-06	1.91e-05	CbGpPWpGaD
Nortriptyline—CYP2D6—Metabolism—MTHFR—polycystic ovary syndrome	2.92e-06	1.91e-05	CbGpPWpGaD
Nortriptyline—CYP2C9—Metabolism—MTHFR—polycystic ovary syndrome	2.9e-06	1.89e-05	CbGpPWpGaD
Nortriptyline—ALB—Metabolism—PPARG—polycystic ovary syndrome	2.87e-06	1.87e-05	CbGpPWpGaD
Nortriptyline—ALB—Metabolism—POMC—polycystic ovary syndrome	2.83e-06	1.85e-05	CbGpPWpGaD
Nortriptyline—ALB—Metabolism—INS—polycystic ovary syndrome	2.82e-06	1.84e-05	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling by GPCR—IL6—polycystic ovary syndrome	2.81e-06	1.83e-05	CbGpPWpGaD
Nortriptyline—CYP1A2—Metabolism—NCOR1—polycystic ovary syndrome	2.8e-06	1.83e-05	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling by GPCR—IL6—polycystic ovary syndrome	2.79e-06	1.82e-05	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—TH—polycystic ovary syndrome	2.78e-06	1.81e-05	CbGpPWpGaD
Nortriptyline—ADRA1D—Signaling Pathways—VEGFA—polycystic ovary syndrome	2.75e-06	1.79e-05	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—SLC2A4—polycystic ovary syndrome	2.71e-06	1.76e-05	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling by GPCR—IL6—polycystic ovary syndrome	2.67e-06	1.74e-05	CbGpPWpGaD
Nortriptyline—CYP1A2—Metabolism—CYP1A1—polycystic ovary syndrome	2.66e-06	1.73e-05	CbGpPWpGaD
Nortriptyline—CYP2C19—Metabolism—PPARG—polycystic ovary syndrome	2.58e-06	1.68e-05	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—CYP19A1—polycystic ovary syndrome	2.54e-06	1.66e-05	CbGpPWpGaD
Nortriptyline—CYP2C19—Metabolism—POMC—polycystic ovary syndrome	2.54e-06	1.66e-05	CbGpPWpGaD
Nortriptyline—CYP2C19—Metabolism—INS—polycystic ovary syndrome	2.53e-06	1.65e-05	CbGpPWpGaD
Nortriptyline—CYP1A2—Metabolism—MTHFR—polycystic ovary syndrome	2.48e-06	1.61e-05	CbGpPWpGaD
Nortriptyline—DRD2—Signaling by GPCR—IL6—polycystic ovary syndrome	2.47e-06	1.61e-05	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling by GPCR—IL6—polycystic ovary syndrome	2.43e-06	1.58e-05	CbGpPWpGaD
Nortriptyline—HRH1—Signaling by GPCR—IL6—polycystic ovary syndrome	2.42e-06	1.58e-05	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling by GPCR—IL6—polycystic ovary syndrome	2.41e-06	1.57e-05	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling by GPCR—IL6—polycystic ovary syndrome	2.41e-06	1.57e-05	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling Pathways—VEGFA—polycystic ovary syndrome	2.4e-06	1.56e-05	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling Pathways—VEGFA—polycystic ovary syndrome	2.39e-06	1.56e-05	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling by GPCR—IL6—polycystic ovary syndrome	2.38e-06	1.55e-05	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling by GPCR—IL6—polycystic ovary syndrome	2.38e-06	1.55e-05	CbGpPWpGaD
Nortriptyline—CYP2D6—Metabolism—PPARG—polycystic ovary syndrome	2.37e-06	1.55e-05	CbGpPWpGaD
Nortriptyline—CYP2C9—Metabolism—PPARG—polycystic ovary syndrome	2.35e-06	1.53e-05	CbGpPWpGaD
Nortriptyline—CYP2D6—Metabolism—POMC—polycystic ovary syndrome	2.34e-06	1.52e-05	CbGpPWpGaD
Nortriptyline—CYP2D6—Metabolism—INS—polycystic ovary syndrome	2.33e-06	1.52e-05	CbGpPWpGaD
Nortriptyline—CYP2C9—Metabolism—POMC—polycystic ovary syndrome	2.32e-06	1.51e-05	CbGpPWpGaD
Nortriptyline—CYP2C9—Metabolism—INS—polycystic ovary syndrome	2.31e-06	1.5e-05	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling Pathways—VEGFA—polycystic ovary syndrome	2.28e-06	1.49e-05	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—GNAS—polycystic ovary syndrome	2.27e-06	1.48e-05	CbGpPWpGaD
Nortriptyline—HTR6—Signaling Pathways—IL6—polycystic ovary syndrome	2.24e-06	1.46e-05	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—NCOR1—polycystic ovary syndrome	2.16e-06	1.41e-05	CbGpPWpGaD
Nortriptyline—CHRM4—Signaling Pathways—IL6—polycystic ovary syndrome	2.11e-06	1.38e-05	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—VEGFA—polycystic ovary syndrome	2.11e-06	1.37e-05	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—VEGFA—polycystic ovary syndrome	2.07e-06	1.35e-05	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—VEGFA—polycystic ovary syndrome	2.07e-06	1.35e-05	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—VEGFA—polycystic ovary syndrome	2.06e-06	1.34e-05	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—VEGFA—polycystic ovary syndrome	2.05e-06	1.34e-05	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—CYP1A1—polycystic ovary syndrome	2.05e-06	1.34e-05	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—VEGFA—polycystic ovary syndrome	2.04e-06	1.33e-05	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—VEGFA—polycystic ovary syndrome	2.03e-06	1.32e-05	CbGpPWpGaD
Nortriptyline—CHRM5—Signaling Pathways—IL6—polycystic ovary syndrome	2.02e-06	1.32e-05	CbGpPWpGaD
Nortriptyline—CYP1A2—Metabolism—PPARG—polycystic ovary syndrome	2.01e-06	1.31e-05	CbGpPWpGaD
Nortriptyline—CYP1A2—Metabolism—POMC—polycystic ovary syndrome	1.98e-06	1.29e-05	CbGpPWpGaD
Nortriptyline—CYP1A2—Metabolism—INS—polycystic ovary syndrome	1.97e-06	1.28e-05	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—MTHFR—polycystic ovary syndrome	1.91e-06	1.25e-05	CbGpPWpGaD
Nortriptyline—ADRA1D—Signaling Pathways—IL6—polycystic ovary syndrome	1.9e-06	1.24e-05	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling Pathways—IL6—polycystic ovary syndrome	1.66e-06	1.08e-05	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling Pathways—IL6—polycystic ovary syndrome	1.65e-06	1.08e-05	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling Pathways—IL6—polycystic ovary syndrome	1.58e-06	1.03e-05	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—PPARG—polycystic ovary syndrome	1.55e-06	1.01e-05	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—POMC—polycystic ovary syndrome	1.53e-06	9.96e-06	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—INS—polycystic ovary syndrome	1.52e-06	9.91e-06	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—IL6—polycystic ovary syndrome	1.46e-06	9.49e-06	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—IL6—polycystic ovary syndrome	1.43e-06	9.34e-06	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—IL6—polycystic ovary syndrome	1.43e-06	9.32e-06	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—IL6—polycystic ovary syndrome	1.43e-06	9.29e-06	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—IL6—polycystic ovary syndrome	1.42e-06	9.26e-06	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—IL6—polycystic ovary syndrome	1.41e-06	9.17e-06	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—IL6—polycystic ovary syndrome	1.4e-06	9.15e-06	CbGpPWpGaD
